Bladder Cancer Treatment

Bladder cancer affects the lining of the bladder wall, commonly presenting as non–muscle-invasive disease but ranging to muscle‑invasive or metastatic cases. Treatment pathways include transurethral resection of bladder tumor (TURBT) for early-stage disease, followed by intravesical BCG or chemotherapy. Muscle-invasive or high-risk tumors often require radical cystectomy (± urinary reconstruction) sometimes coupled with neoadjuvant or adjuvant chemotherapy. Radiation or systemic immunotherapy may be employed in select or metastatic cases. Countries such as India, Turkey, Mexico, and Germany provide internationally accredited care with high success rates (~75‑80% 5‑year survival) and substantial cost advantages. Positioned in Luxora’s oncology continuum alongside colorectal care, offering a balanced mix of surgical and systemic therapies tailored by tumor stage.